Advertisement

Topics

Search Results for "Sangart Pharma"

08:09 EDT 25th June 2017 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Matching News

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment due to extraordinary dividend in Karo Pharma (14/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published April 10, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Annual ...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment due to extraordinary dividend in Karo Pharma (13/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published March 31, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Annual ...

CEO of LEO Pharma on how they are driving collaborations

Précis: Gitte Aabo, CEO, LEO Pharma speaking at eyeforpharma Barcelona on what LEO Pharma are doing to drive collaborations and create more value for patients and healthcare.YouTube URL: ht...

Mezzion hires Pol Pharma and Halo Pharma and accuses Dr Reddy's of fraud

Mezzion has hired Pol Pharma and Halo Pharma and accused former CMO Dr Reddy’s of hiding manufacturing problems that cost its erectile dysfunction candidate, udenafil, US approval.

Verona Pharma plc: Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for...

Verona Pharma plc: Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA

June 5, 2017, LONDON - Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics f...

#jobs #lifescience Tax Manager – Biotech/Pharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Tax Manager – Biotech/Pharma .MA-Boston, Tax Manager – Biotech/Ph...

Big Pharma Outlook 2025, An Infographic

Big Pharma is poised for growth because of strong launch portfolios, the availability of high-potential pipeline assets, and a focus...    

Matching PubMed Articles

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Clinical Trials Series - Large Pharma.

Scratching the Career Itch Leads To Bigger Reach in Pharma.

Arkansas execution proceeds as pharma companies lose battle to stop use of their drugs.

An open source pharma roadmap.

In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement